ArticleCurrent health sciences journal
The Assessment of T-Lymphocytes In Gastric Adenocarcinomas.
Article in Current health sciences journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric adenocarcinomas (GAC) are common cancers in pathology, which pose real problems in practice due to heterogeneity, response to treatment and prognosis. New therapeutic approaches in GAC are aimed at activating the immune system by unblocking or modulating it. In this study, we analyzed the density and distribution of intra- and peritumoral CD4 and CD8 lymphocytes, by immunohistochemistry, in relation to the main prognostic parameters of GAC. CD4 and CD8 lymphocytes were superior in the tumor compartments in the case of discohesive and mixed GAC. They also predominated in discohesive GAC with signet ring cells at the intratumoral level and in those without other specifications at the peritumoral level. CD4 and CD8 were superior in high-grade GAC, in stages II/III and with lymphovascular invasion, more frequently peritumoral. The study indicated differences in the distribution of CD4 and CD8 T lymphocytes that may be useful for improving patient stratification for personalized targeted therapy of GAC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.